订单组设计对儿科静脉注射液指南遵守的影响:一项国家研究
Matthew C Nordstrom1, Kathleen D Bonsmith1, Chuan Zhou2,3
1Department of Pediatrics, University of California, San Francisco, San Francisco, California.
Hospital pediatrics
|March 11, 2026
概括
修改医院订单组以列出符合指南的静脉注射液 (IVF) 选项首先改善了对最佳实践的遵守. 这一策略提高了临床医生的效率和患者护理,而不会影响患者的自主权.
科学领域:
- 临床信息学 临床信息学
- 改善医疗保健质量 改善医疗保健质量
- 患者安全 患者安全
背景情况:
- 住院医院流体标准化 (SOFI) 试验旨在改善静脉注射流体 (IVF) 的使用.
- 医院订单设置设计可以影响临床实践和患者的结果.
研究的目的:
- 描述SOFI试验中的订单集设计和决策驱动因素.
- 探索订单组设计和指导方针一致的单独同位素试管婴儿使用之间的关联.
主要方法:
- 调查了100个网站领导者关于订单组修改和设计驱动器.
- 使用定性数据的专题分析和定量数据的回归模型.
- 将调查数据与SOFI试验数据联系起来,以评估遵守指南.
主要成果:
- 订单组的修改包括优先考虑同位素试管婴儿和删除低位素选项.
- 关键的设计驱动因素是个性化护理,IT限制和临床医生的自主权.
- 在没有预选的情况下首先列出同位素试管婴儿,增加了3.5%的坚持 (P=.005).
结论:
- 订单设计对遵守临床指南有重大影响.
- 在电子系统中优先考虑符合指南的订单可以提高效率和结果.
- 这种方法支持临床医生的自主性和患者群体的广泛适用性.
相关概念视频
Drug Dosing: Infants and Children
669
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
669
Pharmacokinetics in Pediatric Patients: Drug Distribution
414
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
414
Pharmacokinetics in Pediatric Patients: Drug Excretion
349
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
349
One-Compartment Open Model for IV Bolus Administration: General Considerations
885
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
885
Acute Kidney Injury VI: Nursing Management
626
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
626
Dosage Regimens: Designs and Approaches
434
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
434


